Boiron SA (BOIRF)

Market Cap	613.90M +28.6%
Revenue (ttm)	592.91M +4.8%
Net Income	22.75M -18.2%
EPS	1.31 -18.2%
Shares Out	n/a
PE Ratio	26.99
Forward PE	18.95
Dividend	n/a
Ex-Dividend Date	n/a

Volume	200
Average Volume	345
Open	30.00
Previous Close	31.87
Day's Range	30.00 - 30.00
52-Week Range	24.00 - 32.28
Beta	0.46
RSI	43.40
Earnings Date	Mar 20, 2026

About Boiron

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products, including medical devices, invitro diagnostics, herbal medicine, food supplements, cosmetics, and CBD-based products. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for a...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1932
• Employees: 2,736
• Stock Exchange: OTCMKTS
• Ticker Symbol: BOIRF

Financial Performance

In 2024, Boiron's revenue was 487.56 million, a decrease of -1.15% compared to the previous year's 493.25 million. Earnings were 11.34 million, a decrease of -68.36%.

Financial numbers in EUR